GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 259 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2020. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $24,582,000 | -1.3% | 360,956 | -53.7% | 0.17% | -15.6% |
Q2 2022 | $24,910,000 | -5.0% | 779,691 | +3.0% | 0.20% | +15.2% |
Q1 2022 | $26,211,000 | +38.1% | 756,708 | +16.7% | 0.18% | +47.1% |
Q4 2021 | $18,977,000 | +123.0% | 648,339 | +94.1% | 0.12% | +108.6% |
Q3 2021 | $8,511,000 | +23.8% | 334,041 | +70.1% | 0.06% | +23.4% |
Q2 2021 | $6,875,000 | +60.5% | 196,330 | +189.4% | 0.05% | +4.4% |
Q2 2020 | $4,283,000 | +22.5% | 67,843 | +50.8% | 0.04% | +15.4% |
Q1 2020 | $3,497,000 | -2.2% | 45,000 | 0.0% | 0.04% | +2.6% |
Q4 2019 | $3,577,000 | -9.2% | 45,000 | -53.1% | 0.04% | -37.7% |
Q4 2018 | $3,941,000 | -36.8% | 96,000 | -41.5% | 0.06% | -26.5% |
Q3 2018 | $6,232,000 | +51.5% | 164,000 | +80.2% | 0.08% | +27.7% |
Q2 2018 | $4,113,000 | +10.6% | 91,000 | +18.2% | 0.06% | +3.2% |
Q1 2018 | $3,719,000 | -11.7% | 77,000 | -28.0% | 0.06% | -13.7% |
Q4 2017 | $4,210,000 | +39.8% | 107,000 | +10.3% | 0.07% | +37.7% |
Q3 2017 | $3,012,000 | +32.7% | 97,000 | +16.9% | 0.05% | +23.3% |
Q2 2017 | $2,270,000 | -20.0% | 83,000 | +7.8% | 0.04% | -21.8% |
Q1 2017 | $2,838,000 | +155.0% | 77,000 | 0.0% | 0.06% | +111.5% |
Q4 2016 | $1,113,000 | -19.5% | 77,000 | +28.3% | 0.03% | -21.2% |
Q3 2016 | $1,383,000 | +138.0% | 60,000 | +71.4% | 0.03% | +120.0% |
Q2 2016 | $581,000 | – | 35,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |